White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

Cognitive function in cystic fibrosis and cystic fibrosis related diabetes (CFRD)

Chadwick, Helen Kay (2016) Cognitive function in cystic fibrosis and cystic fibrosis related diabetes (CFRD). PhD thesis, University of Leeds.

[img] Text
Chadwick HK FINAL THESIS DOCUMENT. postVIVA. 06.04.2017.pdf - Final eThesis - complete (pdf)
Restricted until 1 May 2022.

Request a copy


Cystic fibrosis (CF) is a complex multisystem disease caused by a gene mutation of a protein called the CF Transmembrane Conductance Regulator (CFTR). Glucose tolerance abnormalities are common in CF and the prevalence of CF related diabetes (CFRD), which shares clinical characteristics with type 1 (T1DM) and type 2 diabetes (T2DM), increases with age. Impaired glucose tolerance (IGT), T1DM and T2DM are associated with cognitive impairment relative to healthy controls. The overall aim of this thesis was to examine cognitive function in CF. Study 1 investigated the impact of CF on cognitive function, in people with CFRD (n=49), people with CF who are not diabetic (CFND, n=49) and healthy controls (n=49). Memory, attention and processing speed, and cognitive flexibility was impaired in CFRD, and to a lesser degree in CFND, relative to healthy controls. Study 2 assessed cognitive function over a 1-3 year period in people with CFRD (N=36) and found no evidence of cognitive decline despite a decline in lung function. Study 3 compared cognitive function in people with CFRD who were post transplant (CFRDTx, n=18), people with CFRD (who were not post transplant, n=18), and healthy controls (n=18). CFRD was associated with impairment in attention and processing speed, spatial working memory, cognitive flexibility and to a lesser extent verbal memory. Cognitive function did not improve post transplantation in people with CFRD. Study 4 followed up people with CFRDTx (N=8) over an 18±6 month period and found no decline in cognitive function. Taken together, the evidence presented in this thesis suggests that diabetes in CF is associated with cognitive impairment, and that maintaining glycaemic control protects against cognitive decline. The cognitive impairment observed in people with CF is of clinical significance and has implications for self care and disease management. The recent discovery that CFTR is present in the pancreas and the brain has important implications for the effects of the new CFTR potentiator and corrector therapies on cognitive function in CF.

Item Type: Thesis (PhD)
Keywords: cystic fibrosis, cystic fibrosis related diabetes, CFRD, cognitive function, CANTAB, transplantation, diabetes, glycaemic control
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Psychological Sciences (Leeds)
Depositing User: Dr Helen Kay Chadwick
Date Deposited: 19 Apr 2017 11:47
Last Modified: 19 Apr 2017 11:47
URI: http://etheses.whiterose.ac.uk/id/eprint/16912

Please use the 'Request a copy' link(s) above to request this thesis. This will be sent directly to someone who may authorise access.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.

Actions (repository staff only: login required)